Explore more publications!
The Middle East Health Journal
Got News to Share?

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 22, 2025

Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 22, 2025

Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™
December 22, 2025

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

Indeterminate GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends
December 22, 2025

XOMA Royalty Declares Quarterly Preferred Stock Dividends

Indeterminate GlobeNewswire
Secura Bio Provides Corporate Update and Highlights Progress in its Phase 3 TERZO Study
December 22, 2025

Secura Bio Provides Corporate Update and Highlights Progress in its Phase 3 TERZO Study

Indeterminate GlobeNewswire
Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
December 22, 2025

Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Indeterminate GlobeNewswire
Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026
December 22, 2025

Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026

Indeterminate GlobeNewswire
Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal
December 22, 2025

Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal

Indeterminate GlobeNewswire
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved
December 22, 2025

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

Indeterminate GlobeNewswire
Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor
December 22, 2025

Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor

Indeterminate GlobeNewswire
和誉医药CSF-1R抑制剂贝捷迈®获NMPA批准，填补中国腱鞘巨细胞瘤系统性治疗空白
December 22, 2025

和誉医药CSF-1R抑制剂贝捷迈®获NMPA批准，填补中国腱鞘巨细胞瘤系统性治疗空白

Indeterminate GlobeNewswire
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
December 22, 2025

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

Indeterminate GlobeNewswire
Biosplice Therapeutics Announces First Patient Dosed in Investigator‑Initiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD Platinum‑Resistant Ovarian Cancer
December 22, 2025

Biosplice Therapeutics Announces First Patient Dosed in Investigator‑Initiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD Platinum‑Resistant Ovarian Cancer

Indeterminate GlobeNewswire
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
December 22, 2025

Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

Indeterminate GlobeNewswire
Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
December 22, 2025

Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate

Indeterminate GlobeNewswire
Ipsen élargit son portefeuille de produits en développement précoce avec un conjugué anticorps-médicament innovant développé par Simcere Zaiming
December 22, 2025

Ipsen élargit son portefeuille de produits en développement précoce avec un conjugué anticorps-médicament innovant développé par Simcere Zaiming

Indeterminate GlobeNewswire
Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13
December 22, 2025

Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions